Razekan Biolabs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.96 M
- Revenue Growth -43.24%
- Profit Growth -274.04%
- Ebitda -167.66%
- Net Worth -2.95%
- Total Assets -8.42%
About Razekan Biolabs
Razekan Biolabs Private Limited (RBPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 March 2011 and has a history of 13 years and ten months. Its registered office is in Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.96 M.
Rajiv Dhaor and Kanwal Rattan serve as directors at the Company.
Company Details
-
Location
Delhi, Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232DL2011PTC216732
-
Company No.
216732
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Mar 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Razekan Biolabs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Dhaor
|
Director | 29-Mar-2011 | Current |
|
Kanwal Rattan
|
Director | 29-Mar-2011 | Current |
Financial Performance of Razekan Biolabs.
Razekan Biolabs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 43.24% decrease. The company also saw a substantial fall in profitability, with a 274.04% decrease in profit. The company's net worth dipped by a decrease of 2.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Razekan Biolabs?
In 2023, Razekan Biolabs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.96 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jul 2020 | Others | ₹0.16 M | Open |
| 20 Mar 2020 | Others | ₹0.80 M | Open |
How Many Employees Work at Razekan Biolabs?
Unlock and access historical data on people associated with Razekan Biolabs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Razekan Biolabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Razekan Biolabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.